Burgos

Spain

84 total trials 41 recruiting

Filter these 84 trials by phase, condition, sponsor and more.

Open in Search →

A Phase 3 Study of Obexelimab in Patients with Warm Autoimmune Hemolytic Anemia Ended

2022-501005-12-00 5 2023-09-22 WARM AUTOIMMUNE HEMOLYTIC ANEMIA
A Phase 1, Multicentre, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single IV Dose of Rezafungin Acetat … Ended

2022-501985-23-00 3 2023-05-18 Fungal infections
A study to evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of treatment in children and adolescents with ASD Ended

2024-512202-25-00 4 2023-02-27 Irritability associated with autistic disorder in children and adolesc
A Phase 2a, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington’s D … Ended

2023-509835-26-00 4 2022-07-06 Huntington’s Disease
Study Comparing Bemarituzumab plus Chemotherapy with Placebo and Chemotherapy in Previously Untreated Advanced Gastric or Gastroesophageal J … Ended

2023-505457-40-00 5 2022-02-02 Previously Untreated Advanced Gastric or Gastroesophageal Junction Can
Randomised, double-blind, placebo-controlled study to evaluate the effect of metformin, an AMPK activator, on cognitive measures of progress … Ended

2024-518875-73-00 5 2021-12-10 Huntington Disease
MENACWY=MEN7B-003 Ended

2023-506449-40-00 9 2021-11-29 Infections, Meningococcal
The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic … Ended

2024-517251-12-00 5 2021-11-02 Recurrent or metastatic head and neck squamous cell carcinoma
A clinical study of OPT-302 with ranibizumab compared to ranibizumab alone in patients with neovascular age-related macular degeneration Ended

2024-512879-13-00 5 2021-09-23 Neovascular age-related macular degeneration (wet AMD)
A Clinical Trial to Test the Safety, Effect, and Activity of Rilzabrutinib (PRN1008) in Adult and Adolescent Patients with Persistent or Chr … Ended

2023-509401-71-00 5 2021-02-05 Immune Thrombocytopenia (ITP)
Phase 3 Study of Tamibarotene Plus Azacitidine in Patients Selected for RARA-positive Higher-risk MDS (SELECT-MDS-1) Ended

2023-510361-97-00 5 Newly Diagnosed RARA-positive Adult Patients with Higher-risk Myelodys
Simvastatin in the Prevention of Recurrent Pancreatitis, a Triple Blind, Randomized Controlled Trial. Ended

2024-513188-17-03 6 Recurrent pancreatitis

Showing 73–84 of 84 trials